Shareholding disclosure

HBM BioVentures AG

Declared position

4.67%

Threshold

Crossed upwards

Timeline

Published

03.09.2011

Transaction

01.09.2011

Transfer date

01.09.2011

Voting rights breakdown

Voting rights acquired4.67%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAB9200028

Beneficial owner

HBM BioVentures AG

Declared address

HBM BioVentures AG, 6300 Zug

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

HBM BioVentures AG

HBM Healthcare Investments AG03.09.2011TAB9200028

Disclosure summary

HBM BioVentures AG disclosed a holding in HBM Healthcare Investments AG on the acquisition side, published by SIX Exchange Regulation on 03.09.2011, at 4.67% of voting rights. Notice category: Single shareholder.

Disclosed position

4.67%

Voting rights acquired

Voting rights acquired4.67%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

HBM BioVentures AG disclosed a holding in HBM Healthcare Investments AG, published on 03.09.2011.

Publication date03.09.2011

Transaction date01.09.2011

Transfer date01.09.2011

Issuing companyHBM Healthcare Investments AG

Beneficial ownerHBM BioVentures AG

Declared addressHBM BioVentures AG, 6300 Zug

CategorySingle shareholder

Voting rights acquired4.67%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAB9200028

Commercial register

CHE-101.849.760

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 03.09.2011

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open